Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of 10 citing Kusaka: Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity:.... (0.12 sec) 

Anti-vascular endothelial growth factor and retinopathy of prematurity

- prsjournal.com
JE Sears - British Journal of Ophthalmology, 2008 - bjo.bmj.com
Retinopathy of prematurity1 (ROP) has been at the nexus of a progressive
understanding of neovascularisation, in large part because of the mouse model of
oxygen-induced retinopathy (OIR) developed by Lois Smith.2 This model has ...
Cited by 3 - Related articles - All 5 versions

Bevacizumab (Avastin) for the Treatment of Ocular Disease


JB Gunther, MM Altaweel - Survey of Ophthalmology, 2009 - Elsevier
The use of intravitreal bevacizumab (Avastin) has greatly expanded since its
introduction into ophthalmic care 3 years ago. A PubMed search on 1 August 2008
revealed 51 ocular disease processes that have been treated with ...
Cited by 2 - Related articles - All 23 versions

Antivascular endothelial growth factor for retinopathy of prematurity

- duanessolution.com
HA Mintz-Hittner, LM Best - Current Opinion in Pediatrics, 2009 - journals.lww.com
Introduction Retinopathy of prematurity (ROP) remains a significant morbidity in
extremely immature infants whose survival rate continues to increase [1–4].
Traditional treatment for acute phase ROP has evolved from cryotherapy ...
Cited by 1 - Related articles - All 3 versions

A Systematic Analysis of the Off-Label Use of Bevacizumab for Severe Retinopathy of …


JA Micieli, M Surkont, AF Smith - American Journal of Ophthalmology, 2009 - Elsevier
Nine articles, including 6 case reports, 2 retrospective studies, and 1
prospective case series representing 77 eyes of 48 infants, were selected for
the review. The doses used ranged from 0.4 to 1.25 mg, with 0.75 mg being ...
Related articles - All 14 versions

Lens-Sparing Vitrectomy Effective for Reattachment of Newly Developed Falciform Retinal …


C Shima, S Kusaka, H Kondo, H Hasebe, T … - Archives of Ophthalmology, 2009 - archopht.highwire.org
Norrie disease (ND) is an inherited eye disease caused by mutations in the
Norrie disease protein gene, 1 and it is characterized by congenital blindness
due to malformations of the retina. 2 Patients are rarely seen before they ...
Related articles - All 2 versions

Effect of Early Vitreous Surgery for Aggressive Posterior Retinopathy of Prematurity …


S Nishina, T Yokoi, T Yokoi, Y Kobayashi, M … - Ophthalmology, 2009 - Elsevier
All eyes underwent vitrectomy with lensectomy that removed the vitreous gel
around the fibrovascular proliferative tissue, but not the proliferative tissue
when fibrovascular proliferation and retinal detachment occurred despite ...
Related articles - All 2 versions

Simultaneous Analyses of Vitreous Levels of 27 Cytokines in Eyes with Retinopathy of …


T Sato, S Kusaka, H Shimojo, T Fujikado - Ophthalmology, 2009 - Elsevier
The ROP eyes were divided into 2 groups according to vascular activity: 12 eyes
with vascularly active ROP and 15 eyes with vascularly inactive ROP. Undiluted
vitreous samples were collected, and the vitreous concentrations of 27 ...
Related articles - All 2 versions

[CITATION] Paradoxical vascular–fibrotic reaction after intravitreal bevacizumab for retinopathy of …


LC Zepeda-Romero, JA Liera-Garcia, JA … - Eye, 2009 - nature.com
Jump to main content; Jump to navigation; nature.com homepage; Publications AZ index;
Browse by subject. My account; Submit manuscript; Register; Subscribe; RCOphth ...
Related articles - All 3 versions

Current Surgical Techniques in the Management for Retinopathy of Prematurity


LY Ho, MT Trese - Techniques in Ophthalmology, 2009 - journals.lww.com
Abstract: The management and understanding of retinopathy of pre- maturity (ROP)
have improved immensely ever since being originally described in the early
1940s. Over the course of the last half century, what was once a ...
Related articles

Akute Retinopathia praematurorum


B Lorenz - Der Ophthalmologe, 2008 - Springer
Die Frühgeborenenretinopathie (ROP) ist nach wie vor ein sehr aktuelles The-
ma, obwohl ihre Erstbeschreibung be- reits 66 Jahre zurückliegt [15]. Sie
stellt ei- ne lebenslange Erkrankung dar, deren ge- schichtliche ...
Related articles - All 2 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google